Skip to main content
. 2016 Jan 25;7(8):9448–9461. doi: 10.18632/oncotarget.7021

Figure 7. Association between postoperative survival and hepatic miR-100, PLK1 and HBV polymerase antigen expression.

Figure 7

A and B. Kaplan-Meier analysis for postoperative recurrence-free survivals between HCC patients expressing high and low hepatic levels of miR-100 (A) or PLK1 (B). C and D. Combined analysis of postoperative recurrence-free survival. (C), between patients with hepatic HBV polymerase antigen (+)/(−) and miR-100 high/low levels; (D), between patients with hepatic HBV polymerase antigen (+)/(−) and PLK1 high/low levels.